Donor‐type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors
British Journal of Haematology · 2023-06 · 201 (6) · 1159-1168
DOI: 10.1111/bjh.18761 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 22.03.2023. Verfasst von Andrea Jarisch und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Department for Children and Adolescents, Goethe University Frankfurt,…. Hauptthemen laut MEDLINE: Red-Cell Aplasia, Pure, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
ABO incompatibility affects approximately 40% of allogeneic stem cell transplants in Caucasian patient populations. Because bone marrow (BM), the preferred graft from paediatric sibling donors and for non‐malignant diseases, has a red blood cell (RBC) content similar to blood, anti‐donor isoagglutinins must either be depleted from the recipient or RBCs removed from the graft. To achieve tolerability of unmanipulated BM grafts, we used controlled infusions of donor ABO‐type RBC units to deplete isoagglutinins before the transplant. This retrospective study evaluates the outcomes of 52 ABO major incompatible BM transplants performed at our centre between 2007 and 2019. The use of donor‐type RBC transfusions was well tolerated. They effectively reduced isoagglutinins levels, typically achieving target titres after one (60%) or two (29%) transfusions. The approach allowed for successful and uneventful infusions of unmanipulated BM which provided timely engraftment. The transplant outcomes were not inferior to those of a matched‐pair control group of patients with ABO‐identical donors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Department for Children and Adolescents, Goethe University Frankfurt, University Hospital, Frankfurt/Main, Germany.
- Institute of Transfusion Medicine and Immunohematology, Goethe University Frankfurt, Frankfurt, Germany.
- Red Cross Blood Donor Service, Baden Württemberg-Hessen, Frankfurt, Germany.
ORCID-Profile: Andrea Jarisch, Shahrzad Bakhtiar, Laura Moser, Jan-Henning Klusmann, Peter Bader, Halvard Bonig
Zitieren
APA
Jarisch, A., Salzmann-Manrique, E., Soerensen, J., Sach, G., Rettinger, E., Willasch, A., Bakhtiar, S., Klarmann, D., Bräuninger, S., Moser, L., Fekadu, J., Hutter, M., Klingebiel, T., Klusmann, J. H., Bader, P., & Bonig, H. (2023). Donor‐type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors. British Journal of Haematology, 201(6), 1159-1168. https://doi.org/10.1111/bjh.18761
Vancouver
Jarisch A, Salzmann-Manrique E, Soerensen J, Sach G, Rettinger E, Willasch A, et al. Donor‐type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors. British Journal of Haematology. 2023;201(6):1159-1168. doi:10.1111/bjh.18761
BibTeX
@article{Jarisch2023,
author = {Jarisch, Andrea and Salzmann-Manrique, Emilia and Soerensen, Jan and Sach, Gudrun and Rettinger, Eva and Willasch, Andre and Bakhtiar, Shahrzad and Klarmann, Dieter and Bräuninger, Susanne and Moser, Laura and Fekadu, Julia and Hutter, Martin and Klingebiel, Thomas and Klusmann, Jan-Henning and Bader, Peter and Bonig, Halvard},
title = {Donor‐type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors},
journal = {British Journal of Haematology},
year = {2023},
volume = {201},
number = {6},
pages = {1159--1168},
doi = {10.1111/bjh.18761}
}
EUVIMED